Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Y chromosome microdeletion screening using a new molecular diagnostic method in 1030 Japanese males with infertility.

Iijima M, Shigehara K, Igarashi H, Kyono K, Suzuki Y, Tsuji Y, Kobori Y, Kobayashi H, Mizokami A.

Asian J Androl. 2019 Oct 11. doi: 10.4103/aja.aja_97_19. [Epub ahead of print]

PMID:
31603142
2.

Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.

Nohara T, Kato Y, Nakano T, Nakagawa T, Iwamoto H, Yaegashi H, Nakashima K, Iijima M, Kawaguchi S, Shigehara K, Izumi K, Kadono Y, Mizokami A.

Int J Urol. 2019 Sep 11. doi: 10.1111/iju.14099. [Epub ahead of print]

PMID:
31512303
3.

Circulating PD-1+CXCR5-CD4+ T cells underlying the immunological mechanisms of IgG4-related disease.

Kamekura R, Yamamoto M, Takano K, Yabe H, Ito F, Ikegami I, Takaki H, Shigehara K, Suzuki C, Himi T, Takahashi H, Ichimiya S.

Rheumatol Adv Pract. 2018 Oct 17;2(2):rky043. doi: 10.1093/rap/rky043. eCollection 2018.

4.

Metastatic urachal cancer treated effectively with gemcitabine/cisplatin combination chemotherapy and radiotherapy: A case report.

Yaegashi H, Kadomoto S, Naito R, Makino T, Iwamoto H, Nohara T, Shigehara K, Izumi K, Kadono Y, Mizokami A.

Mol Clin Oncol. 2019 Aug;11(2):139-142. doi: 10.3892/mco.2019.1865. Epub 2019 May 22.

5.

Reiter's syndrome following intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma: a report of five cases.

Nakagawa T, Shigehara K, Naito R, Yaegashi H, Nakashima K, Iijima M, Kawaguchi S, Nohara T, Kitagawa Y, Izumi K, Kadono Y, Mizokami A.

Int Cancer Conf J. 2018 Aug 21;7(4):148-151. doi: 10.1007/s13691-018-0342-1. eCollection 2018 Oct.

6.

Initial Experience With Radium-223 Chloride Treatment at the Kanazawa University Hospital.

Nakashima K, Makino T, Kadomoto S, Iwamoto H, Yaegashi H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Matsuo S, Mizokami A.

Anticancer Res. 2019 May;39(5):2607-2614. doi: 10.21873/anticanres.13384.

PMID:
31092459
7.

Quantification of Bone Metastasis of Castration-resistant Prostate Cancer After Enzalutamide and Abiraterone Acetate Using Bone Scan Index on Bone Scintigraphy.

Kadomoto S, Yaegashi H, Nakashima K, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Nakajima K, Mizokami A.

Anticancer Res. 2019 May;39(5):2553-2559. doi: 10.21873/anticanres.13377.

PMID:
31092452
8.

Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review.

Kadomoto S, Shigehara K, Iwamoto H, Yaegashi H, Izumi K, Kadono Y, Mizokami A.

World J Mens Health. 2019 May 2. doi: 10.5534/wjmh.180130. [Epub ahead of print]

9.

Effectiveness of Synthetic Polymer-coated Peripherally Inserted Central Catheter in Patients With Advanced Cancer.

Takezawa Y, Izumi K, Kamijima T, Machioka K, Shima T, Iwamoto H, Nohara T, Shigehara K, Kadono Y, Seto C, Mizokami A.

In Vivo. 2019 May-Jun;33(3):877-880. doi: 10.21873/invivo.11553.

10.

A Case Report of Chyloretroperitoneum Post Living-Donor Transplantation.

Kawaguchi S, Kadono Y, Nohara T, Kato Y, Nakagawa T, Urata S, Yaegashi H, Nakashima K, Iijima M, Shigehara K, Izumi K, Mizokami A.

Urol Int. 2019 Feb 20:1-3. doi: 10.1159/000497108. [Epub ahead of print]

PMID:
30799423
11.

Novel Prevention Procedure for Inguinal Hernia after Robot-Assisted Radical Prostatectomy: Results from a Prospective Randomized Trial.

Kadono Y, Nohara T, Kawaguchi S, Sakamoto J, Iwamoto H, Yaegashi H, Nakashima K, Iijima M, Shigehara K, Izumi K, Mizokami A.

J Endourol. 2019 Apr;33(4):302-308. doi: 10.1089/end.2018.0898. Epub 2019 Mar 20.

PMID:
30767563
12.

Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study.

Nakagawa R, Shigehara K, Aoyama S, Urata S, Ofude M, Miyagi T, Nakashima T, Izumi K, Mizokami A.

J Infect Chemother. 2019 May;25(5):337-340. doi: 10.1016/j.jiac.2019.01.004. Epub 2019 Feb 2.

PMID:
30718193
13.

IL-10+ T follicular regulatory cells are associated with the pathogenesis of IgG4-related disease.

Ito F, Kamekura R, Yamamoto M, Takano K, Takaki H, Yabe H, Ikegami I, Shigehara K, Himi T, Takahashi H, Ichimiya S.

Immunol Lett. 2019 Mar;207:56-63. doi: 10.1016/j.imlet.2019.01.008. Epub 2019 Jan 15.

14.

The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study.

Kato Y, Shigehara K, Nakashima K, Iijima M, Kawagushi S, Nohara T, Izumi K, Kadono Y, Konaka H, Namiki M, Mizokami A.

Aging Male. 2019 Jan 16:1-6. doi: 10.1080/13685538.2018.1550060. [Epub ahead of print]

PMID:
30651019
15.

High-fat diet accelerates extreme obesity with hyperphagia in female heterozygous Mecp2-null mice.

Fukuhara S, Nakajima H, Sugimoto S, Kodo K, Shigehara K, Morimoto H, Tsuma Y, Moroto M, Mori J, Kosaka K, Morimoto M, Hosoi H.

PLoS One. 2019 Jan 4;14(1):e0210184. doi: 10.1371/journal.pone.0210184. eCollection 2019.

16.

Health-related Quality of Life and Toxicity After Single-fraction High-dose-rate Brachytherapy With External Beam Radiotherapy for Localized and Locally Advanced Prostate Cancer.

Makino T, Nakashima K, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Kumano T, Mizokami A.

Anticancer Res. 2019 Jan;39(1):477-486. doi: 10.21873/anticanres.13137.

PMID:
30591498
17.

High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma.

Yaegashi H, Izumi K, Kadomoto S, Naito R, Makino T, Iwamoto H, Nohara T, Shigehara K, Kadono Y, Mizokami A.

Anticancer Res. 2019 Jan;39(1):375-380. doi: 10.21873/anticanres.13122.

PMID:
30591483
18.

Gemcitabine Plus Cisplatin Split Versus Gemcitabine Plus Carboplatin for Advanced Urothelial Cancer With Cisplatin-unfit Renal Function.

Izumi K, Iwamoto H, Yaegashi H, Shigehara K, Nohara T, Kadono Y, Mizokami A.

In Vivo. 2019 Jan-Feb;33(1):167-172. doi: 10.21873/invivo.11454.

19.

Evaluating urinary incontinence before and after radical prostatectomy using the international consultation on incontinence questionnaire-short form.

Machioka K, Kadono Y, Naito R, Nakashima K, Iijima M, Kawaguchi S, Shigehara K, Nohara T, Izumi K, Mizokami A.

Neurourol Urodyn. 2019 Feb;38(2):726-733. doi: 10.1002/nau.23907. Epub 2018 Dec 21.

PMID:
30576037
20.

Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells.

Iwamoto H, Izumi K, Natsagdorj A, Naito R, Makino T, Kadomoto S, Hiratsuka K, Shigehara K, Kadono Y, Narimoto K, Saito Y, Nakagawa-Goto K, Mizokami A.

Prostate. 2019 Apr;79(5):468-479. doi: 10.1002/pros.23753. Epub 2018 Dec 19.

PMID:
30569541
21.

CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells.

Natsagdorj A, Izumi K, Hiratsuka K, Machioka K, Iwamoto H, Naito R, Makino T, Kadomoto S, Shigehara K, Kadono Y, Lin WJ, Maolake A, Mizokami A.

Cancer Sci. 2019 Jan;110(1):279-288. doi: 10.1111/cas.13876. Epub 2018 Dec 7.

22.

Etiological role of human papillomavirus infection in the development of penile cancer.

Sakamoto J, Shigehara K, Nakashima K, Kawaguchi S, Nakashima T, Shimamura M, Yasuda M, Kato T, Hasegawa T, Kobori Y, Okada H, Deguchi T, Izumi K, Kadono Y, Mizokami A.

Int J Infect Dis. 2019 Jan;78:148-154. doi: 10.1016/j.ijid.2018.11.003. Epub 2018 Nov 10.

23.

Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.

Shigehara K, Konaka H, Kato Y, Iijima M, Nakashima K, Kawaguchi S, Nohara T, Izumi K, Namiki M, Mizokami A.

Int J Impot Res. 2019 Jan;31(1):25-30. doi: 10.1038/s41443-018-0065-z. Epub 2018 Aug 22.

PMID:
30135606
24.

Changes in penile length after radical prostatectomy: effect of neoadjuvant androgen deprivation therapy.

Kadono Y, Nohara T, Kawaguchi S, Sakamoto J, Makino T, Nakashima K, Iijima M, Shigehara K, Izumi K, Mizokami A.

Andrology. 2018 Nov;6(6):903-908. doi: 10.1111/andr.12517. Epub 2018 Jul 2.

PMID:
29968337
25.

Effectiveness and Safety of Pegfilgrastim in BEP Treatment for Patients with Germ Cell Tumor.

Iwamoto H, Izumi K, Natsagdorj A, Makino T, Nohara T, Shigehara K, Kadono Y, Mizokami A.

In Vivo. 2018 Jul-Aug;32(4):899-903. doi: 10.21873/invivo.11326.

26.

Risk factors for human papillomavirus detection in urine samples of heterosexual men visiting urological clinics in Japan.

Nakashima K, Shigehara K, Kitamura T, Yaegashi H, Shimamura M, Kawaguchi S, Izumi K, Kadono Y, Mizokami A.

J Infect Chemother. 2018 Sep;24(9):713-717. doi: 10.1016/j.jiac.2018.04.011. Epub 2018 May 11.

PMID:
29759898
27.

Decrement in bone mineral density after parathyroidectomy in a pediatric patient with primary hyperparathyroidism.

Morimoto H, Nakajima H, Mori J, Fukuhara S, Shigehara K, Adachi S, Hosoi H.

Clin Pediatr Endocrinol. 2018;27(2):81-86. doi: 10.1297/cpe.27.81. Epub 2018 Apr 13.

28.

Tumor necrosis factor-α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation.

Maolake A, Izumi K, Natsagdorj A, Iwamoto H, Kadomoto S, Makino T, Naito R, Shigehara K, Kadono Y, Hiratsuka K, Wufuer G, Nastiuk KL, Mizokami A.

Cancer Sci. 2018 May;109(5):1524-1531. doi: 10.1111/cas.13586. Epub 2018 Apr 29.

29.

Investigating the mechanism underlying urinary continence recovery after radical prostatectomy: effectiveness of a longer urethral stump to prevent urinary incontinence.

Kadono Y, Nohara T, Kawaguchi S, Naito R, Urata S, Nakashima K, Iijima M, Shigehara K, Izumi K, Gabata T, Mizokami A.

BJU Int. 2018 Sep;122(3):456-462. doi: 10.1111/bju.14181. Epub 2018 Mar 22.

30.

C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment.

Urata S, Izumi K, Hiratsuka K, Maolake A, Natsagdorj A, Shigehara K, Iwamoto H, Kadomoto S, Makino T, Naito R, Kadono Y, Lin WJ, Wufuer G, Narimoto K, Mizokami A.

Cancer Sci. 2018 Mar;109(3):724-731. doi: 10.1111/cas.13494. Epub 2018 Feb 14.

31.

Serum periostin is associated with body mass index and allergic rhinitis in healthy and asthmatic subjects.

Kimura H, Konno S, Makita H, Taniguchi N, Kimura H, Goudarzi H, Shimizu K, Suzuki M, Shijubo N, Shigehara K, Ono J, Izuhara K, Ito YM, Nishimura M.

Allergol Int. 2018 Jul;67(3):357-363. doi: 10.1016/j.alit.2017.11.006. Epub 2017 Dec 7.

32.

Long-term persistence of human papillomavirus in the skin of the glans penis of elderly men above 80 years of age.

Kitamura T, Suzuki M, Koyama Y, Shigehara K.

Int J STD AIDS. 2018 May;29(6):552-556. doi: 10.1177/0956462417742319. Epub 2017 Nov 20.

PMID:
29157169
33.

Editorial Comment to Influence of dutasteride treatment on serum hormone levels and aging male symptoms in patients with benign prostatic enlargement.

Shigehara K, Mizokami A.

Int J Urol. 2018 Jan;25(1):74-75. doi: 10.1111/iju.13477. Epub 2017 Oct 23. No abstract available.

34.

Both High and Low Serum Total Testosterone Levels Indicate Poor Prognosis in Patients with Prostate Cancer.

Izumi K, Shigehara K, Nohara T, Narimoto K, Kadono Y, Mizokami A.

Anticancer Res. 2017 Oct;37(10):5559-5564.

PMID:
28982870
35.

Androgen replacement therapy for cancer-related symptoms in male advanced cancer patients: study protocol for a randomised prospective trial (ARTFORM study).

Izumi K, Shigehara K, Nohara T, Narimoto K, Kadono Y, Nanjo S, Yamada T, Ohtsubo K, Yano S, Mizokami A.

J Med Invest. 2017;64(3.4):202-204. doi: 10.2152/jmi.64.202.

36.

Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea.

Shigehara K, Konaka H, Sugimoto K, Nohara T, Izumi K, Kadono Y, Namiki M, Mizokami A.

Aging Male. 2018 Jun;21(2):99-105. doi: 10.1080/13685538.2017.1378320. Epub 2017 Sep 18.

PMID:
28920756
37.

Cutting Edge: A Critical Role of Lesional T Follicular Helper Cells in the Pathogenesis of IgG4-Related Disease.

Kamekura R, Takano K, Yamamoto M, Kawata K, Shigehara K, Jitsukawa S, Nagaya T, Ito F, Sato A, Ogasawara N, Tsubomatsu C, Takahashi H, Nakase H, Himi T, Ichimiya S.

J Immunol. 2017 Oct 15;199(8):2624-2629. doi: 10.4049/jimmunol.1601507. Epub 2017 Sep 15.

38.

Evaluation of Factors Affecting Metastasis for Renal Cell Carcinoma Based on Current Guidelines in Japan.

Kadono Y, Kawaguchi S, Nohara T, Shigehara K, Narimoto K, Izumi K, Ikeda H, Yaegashi H, Miyagi T, Nakashima T, Seto C, Mizokami A.

Anticancer Res. 2017 Sep;37(9):5147-5153.

PMID:
28870947
39.

Human papillomavirus prevalence in the anus and urine among HIV-infected Japanese men who have sex with men.

Yaegashi H, Shigehara K, Itoda I, Ohkodo M, Nakashima K, Kawaguchi S, Ueda M, Izumi K, Kadono Y, Ikeda H, Namiki M, Mizokami A.

J Infect Chemother. 2017 Sep;23(9):621-626. doi: 10.1016/j.jiac.2017.06.005. Epub 2017 Jul 6.

PMID:
28688605
40.

Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomised controlled trial (EARTH study).

Shigehara K, Konaka H, Nohara T, Izumi K, Kitagawa Y, Kadono Y, Iwamoto T, Koh E, Mizokami A, Namiki M.

Andrologia. 2018 Feb;50(1). doi: 10.1111/and.12815. Epub 2017 May 12.

PMID:
28497534
41.

Testosterone Deficiency and Nocturia: A Review.

Shigehara K, Izumi K, Mizokami A, Namiki M.

World J Mens Health. 2017 Apr;35(1):14-21. doi: 10.5534/wjmh.2017.35.1.14. Review.

42.

Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study).

Shigehara K, Konaka H, Koh E, Nakashima K, Iijima M, Nohara T, Izumi K, Kitagawa Y, Kadono Y, Sugimoto K, Iwamoto T, Mizokami A, Namiki M.

Aging Male. 2017 Sep;20(3):139-145. doi: 10.1080/13685538.2017.1303829. Epub 2017 Mar 28.

PMID:
28347184
43.

Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice.

Kodo K, Sugimoto S, Nakajima H, Mori J, Itoh I, Fukuhara S, Shigehara K, Nishikawa T, Kosaka K, Hosoi H.

PLoS One. 2017 Mar 13;12(3):e0173661. doi: 10.1371/journal.pone.0173661. eCollection 2017.

44.

Changes in penile length after radical prostatectomy: investigation of the underlying anatomical mechanism.

Kadono Y, Machioka K, Nakashima K, Iijima M, Shigehara K, Nohara T, Narimoto K, Izumi K, Kitagawa Y, Konaka H, Gabata T, Mizokami A.

BJU Int. 2017 Aug;120(2):293-299. doi: 10.1111/bju.13777. Epub 2017 Feb 8.

45.

Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis.

Maolake A, Izumi K, Shigehara K, Natsagdorj A, Iwamoto H, Kadomoto S, Takezawa Y, Machioka K, Narimoto K, Namiki M, Lin WJ, Wufuer G, Mizokami A.

Oncotarget. 2017 Feb 7;8(6):9739-9751. doi: 10.18632/oncotarget.14185.

46.

Slow progression of gastric adenocarcinoma of fundic gland type: a case report.

Kusumoto C, Shigehara K, Take S, Ishiki K, Taniguchi K.

Nihon Shokakibyo Gakkai Zasshi. 2016;113(12):2042-2049. Review. Japanese.

PMID:
27916772
47.

The correlation between highly sensitive C-reactive protein levels and erectile function among men with late-onset hypogonadism.

Shigehara K, Konaka H, Ijima M, Nohara T, Narimoto K, Izumi K, Kadono Y, Kitagawa Y, Mizokami A, Namiki M.

Aging Male. 2016 Dec;19(4):239-243. Epub 2016 Nov 12.

PMID:
27841078
48.

Metastasectomy Improves Survival in Patients with Metastatic Urothelial Carcinoma.

Iwamoto H, Izumi K, Shimura Y, Natsagdorj A, Maolake A, Takezawa Y, Nohara T, Shigehara K, Kadono Y, Mizokami A.

Anticancer Res. 2016 Oct;36(10):5557-5561.

PMID:
27798930
49.

Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma.

Takezawa Y, Izumi K, Shimura Y, Aerken M, Natsagdorji A, Iijima M, Shigehara K, Nohara T, Narimoto K, Kadono Y, Kitagawa Y, Konaka H, Mizokami A.

Anticancer Res. 2016 Sep;36(9):4961-4.

PMID:
27630356
50.

Investigating Urinary Conditions Prior to Robot-assisted Radical Prostatectomy in Search of a Desirable Method for Evaluating Post-prostatectomy Incontinence.

Kadono Y, Nohara T, Kadomoto S, Nakashima K, Iijima M, Shigehara K, Narimoto K, Izumi K, Mizokami A.

Anticancer Res. 2016 Aug;36(8):4293-8.

PMID:
27466547

Supplemental Content

Loading ...
Support Center